TITLE

Orthovita financings add $77M; crystalens maker files for IPO

AUTHOR(S)
Ford, Omar
PUB. DATE
July 2007
SOURCE
Medical Device Daily;7/31/2007, Vol. 11 Issue 144, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the equity offering of Malvern, Pennsylvania-based company Orthovita. The equity offering of the company amounts to $32.5 million. According to the company, proceeds will be used to commercially develop Cortoss, the bone augmentation product and the main revenue generator of the company. Approximately 12.3 million shares of common stock will be offered.
ACCESSION #
25967576

 

Related Articles

  • Orthovita deals add $77M; crystalens maker files IPO.  // Medical Technology & Devices Week;8/6/2007, Vol. 5 Issue 32, p3 

    The article offers information on the $32.5 million equity offering of Orthovita. The offering will be intended for the commercial development of Cortross, a bone augmentation product of the company. According to the firm, it anticipates to offer around 12.3 million shares of common stock. In...

  • BioLase Shares Soar After Tough '05; Laser Gets Makeover. Reed, Vita // Orange County Business Journal;5/1/2006, Vol. 29 Issue 18, p8 

    The article reports on the stock performance of BioLase Technology Inc. as of May 2006. It discusses growth of the Orange County, California-based medical device maker's stock after a challenging 2005. The company has a market value of $240 million to date. The article highlights the increase in...

  • Orthovita: growth through expansions.  // PharmaWatch: Biotechnology;Apr2006, Vol. 5 Issue 4, p23 

    The article reports that orthopedic biomaterials firm Orthovita Inc. is expected to enjoy steady gains in market share and boast revenues of over $116 million by 2009. The forecasted financial performance of the company can be achieved through expansion of the scope of its product portfolio and...

  • Orthovita Launches the Aliquot Directional Bone Tamp.  // Biomedical Market Newsletter;5/14/2011, p245 

    The article reports that Orthovita Inc. announced the launch of the Aliquot(tm) Directional Bone Tamp. The Directional Bone Tamp is a channel creation device that allows safe and targeted placement of Cortoss(tm) Bone Augmentation Material into the vertebral body. The Directional Bone Tamp...

  • Financings roundup.  // Medical Device Daily;10/20/2009, Vol. 13 Issue 202, p3 

    The article reports on the completion by Biomagnetics Diagnostics of its equity financing that is designed to fund its entry into the integrated optical biosensor systems market. The company received about 1 million U.S. dollars from private investors and a philanthropic organization. Clayton...

  • Playing to strengths. Gerrard, Neil // PMJ: Plant Managers Journal;Oct2006, Vol. 33 Issue 9, p29 

    The article focuses on the increase in share price of Vibroplant following its shift from general to specialist plant hire. The company posted a 10.4% increase in revenues from £ 90 million to £ 99.4 million. Profits are rose by 17.7% from £ 10.2 million to £ 12 million. The firm...

  • Dividend increases.  // Dow Theory Forecasts;2/2/2004, Vol. 60 Issue 5, p6 

    The article reports that Intel Corp. has doubled its quarterly dividend to $0.04 per share, payable March , 2003 with an ex-dividend date around February, in the year 2004. L-3 Communications Holdings initiated a cash dividend of $0.10 per share, payable March 15, 2003 with an ex-dividend date...

  • FINANCE.  // New Media Age;11/6/2003, p8 

    Presents an update on the financial performance of media companies in Great Britain as of November 2003. Decline in revenues reported by Pan-European portal Lycos Europe; Number of shares held by NewMedia Spark in ADVFN, which it sold.

  • MARKET WATCH.  // Orange County Business Journal;08/14/2000, Vol. 23 Issue 22, p14 

    Presents charts depicting stock performance of companies in the United States of August 2000. Loss posted by OC 100; Acquisition of Automata International Inc. assets by DDI Corp.; Revenues announced by Emulex Corp.; Reason for the decline of Dense-Pac revenues.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics